Stay updated on T-DM1 Osimertinib Combo for HER2 in NSCLC Clinical Trial

Sign up to get notified when there's something new on the T-DM1 Osimertinib Combo for HER2 in NSCLC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the T-DM1 Osimertinib Combo for HER2 in NSCLC Clinical Trial page

  1. Check
    yesterday
    No Change Detected
  2. Check
    8 days ago
    Change Detected
    Summary
    The ClinicalTrials.gov footer release label changes from v3.7.2 to v3.8.0; the study record and version history remain unchanged.
    Difference
    0.1%
    Check dated 2026-11-01T02:23:56.000Z thumbnail image
  3. Check
    15 days ago
    Change Detected
    Summary
    A notice was added about NIH websites transitioning from the term “Artificial Intelligence” to “Super Intelligence” under Executive Order 14434.
    Difference
    1.0%
    Check dated 2026-10-25T02:24:07.000Z thumbnail image
  4. Check
    22 days ago
    Change Detected
    Summary
    The site footer’s revision label changed from v3.7.1 to v3.7.2.
    Difference
    0.1%
    Check dated 2026-10-18T02:12:50.000Z thumbnail image
  5. Check
    29 days ago
    Change Detected
    Summary
    The site footer revision changes from v3.7.0 to v3.7.1.
    Difference
    0.1%
    Check dated 2026-10-11T02:14:05.000Z thumbnail image
  6. Check
    50 days ago
    Change Detected
    Summary
    A new revision entry v3.7.0 is added to the history and the previous revision v3.6.6 is removed, updating the study record’s version history.
    Difference
    0.1%
    Check dated 2026-09-20T01:17:55.000Z thumbnail image
  7. Check
    71 days ago
    Change Detected
    Summary
    A new revision tag v3.6.6 was added to the study record history, while the previous revision v3.6.5 is removed from the list; this reflects an update to the page's versioning metadata in the history.
    Difference
    0.1%
    Check dated 2026-08-29T19:08:58.000Z thumbnail image

Stay in the know with updates to T-DM1 Osimertinib Combo for HER2 in NSCLC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the T-DM1 Osimertinib Combo for HER2 in NSCLC Clinical Trial page.